T cell protein tyrosine phosphatase (TCPTP) is a tyrosine phosphatase encoded by PTPN2 in humans.{52553} Two splice variants of TCPTP are expressed that contain identical N-termini and catalytic domains but varied C-termini: a 48 kDa form that contains a hydrophobic motif and is targeted to the endoplasmic reticulum and a 45 kDa form that is targeted to the nucleus by a bipartite nuclear localization sequence.{52553,52552} TCPTP is expressed at high levels in cells of hematopoietic origin but is also ubiquitously expressed in all tissues and cell types.{52553} Although the 45 kDa variant of TCPTP is nuclear localized in resting cells, it exits the nucleus in response to various cellular stimuli to dephosphorylate substrates in the cytoplasm and plasma membrane, including PDGFR, c-Met, Src, JAK1, and STAT1, to regulate cell signaling. Knockdown of Ptpn2 induces growth retardation, anemia, increased levels of circulating proinflammatory cytokines, diarrhea, and death in mice by 3 to 5 weeks of age. Protein levels of TCPTP are reduced in BT-483, MDA-MB-134, MDA-MB-157, and MDA-MB-175 breast cancer cells and overexpression of PTPN2 suppresses cell growth in MDA-MB-175 and BT-483 cells.{52552} PTPN2 SNPs have been linked to the development of type I diabetes, rheumatoid arthritis, and Crohn’s disease.{52554} Cayman’s TCPTP (human, recombinant; aa 1-314) protein can be used for enzyme activity applications. This protein consists of 551 amino acids and has a calculated molecular weight of 64.4 kDa. By SDS-PAGE, under reducing conditions, the apparent molecular mass of the protein is 60 kDa.
100 ug
Cayman Chemical
Shipping & storage
Shipping condition
Dry Ice
Storage temperature